On December 5, 2022, SonoThera, Inc. closed the transaction. The round of funding led by Arch Venture Partners, L.P.. The transaction also involved participation from IIF Management Company, LLC, Johnson & Johnson Innovation - JJDC, Inc., Vertex Ventures HC, Medical Excellence Capital, LLC, Eli Lilly and Company, Alexandria Venture Investments, LLC, Lifespan Investments B.v., Formic Ventures, Foothill Ventures, LLC and Wilson Sonsini Goodrich & Rosati, P.C.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
724.9 USD | -1.00% | -2.83% | +24.35% |
02:21pm | Scholz pledges further support for the pharmaceutical industry | DP |
12:11pm | Scholz promises support for pharma sector in Germany as Merck invests | RE |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+24.35% | 660B | |
+24.17% | 562B | |
-6.33% | 358B | |
+19.90% | 322B | |
+7.95% | 297B | |
+13.45% | 219B | |
+6.04% | 199B | |
-10.51% | 196B | |
-12.26% | 149B | |
-6.47% | 146B |
- Stock Market
- Equities
- LLY Stock
- News Eli Lilly and Company
- SonoThera, Inc. announced that it has received $60.75 million in funding from a group of investors